• Home
  • Victims
    • Vaccine Victims Memorial
    • Gardasil & Silgard
      • G / S Australasia
        • G / S Australia
        • G / S New Zealand
      • G / S Europe
        • G / S Czech Republic
        • G / S Denmark
        • G / S France
        • G / S Germany
        • G / S Ireland
        • G / S Italy
        • G / S Norway
        • G / S Scotland
        • G / S Spain
        • G / S United Kingdom
      • G / S N. America
        • G / S Canada
        • G / S Mexico
        • G / S United States
      • G / S S. America
        • G / S Brazil
        • G/S Colombia
    • Cervarix
      • Cervarix Asia
        • Cervarix India
        • Cervarix Philippines
      • Cervarix Europe
        • Cervarix Czech
        • Cervarix Netherlands
        • Cervarix Scotland
        • Cervarix Slovakia
        • Cervarix Spain
        • Cervarix UK
      • Cervarix N. America
        • Cervarix Mexico
  • Resources
    • HPV Testing Resources
      • Pre-HPV Vaccination
      • Post-HPV Vaccination
    • Medical Professionals
    • Vaccine Injury Attorneys
    • Political Action Groups
    • Vaccine Groups
    • Vaccine Victims Hotline
  • SANE Vax Press Releases
  • Videos
    • Vaccine Safety Videos
    • Vaccine Victim Videos
    • Pharma Videos
  • About
    • About Us
    • Who We Are
    • Press Releases
    • SANE Vax in the News
    • Contact Us

SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

  • NEWS
    • Government Agencies
      • African
      • Asian
      • Australasian
      • European
      • North American
      • South American
      • United Nations
      • WHO
    • Pharmaceutical Companies
      • CSL Biotherapies
      • GlaxoSmithKline
      • Inovio Pharmaceuticals
      • Liquidia Technologies
      • Merck & Co.
      • Novartis
      • Pfizer
      • Qiagen
      • Sanofi Aventis
      • Sanofi Pasteur MSD spmsd
      • Wyeth Laboratories
    • Science & Medicine
      • Cancer
      • Clinical Trials
      • Environmental Health
      • Heavy Metal Toxicity
      • HPV Science
      • Influenza
      • Meningitis
      • Pertussis
      • Pharmaceuticals
      • Rotavirus
      • STD’s
      • Vaccine Science
      • Women’s Health
    • Vaccine Adverse Events
    • Vaccine Injury Reporting
      • VAERS
      • VAMPSS
    • Vaccine Litigation
    • Vaccine Marketing
    • Vaccine Politics/People
    • Vaccine Victims
      • Cervarix Injuries
      • DTP/DTaP Injuries
      • Fluvax Injuries
      • Fluzone Injuries
      • Gardasil / Silgard Injuries
      • Menomune Injuries
      • MMR Injuries
      • Polio Vaccine Injuries
      • Synflorix Injuries
      • Yellow Fever Vaccine
    • Vaccines
      • Anthrax
      • Breast Cancer
      • Chicken Pox
      • Cholera
      • Combination Vaccines
      • Diphtheria
      • Hepatitis B
      • HPV
      • Influenza Vaccines
      • Malaria
      • Measles
      • Meningitis Vaccines
      • MRSA
      • Mumps
      • Norovirus
      • Pertussis Vaccines
      • Pneumococcal Disease
      • Polio
      • Rotavirus Vaccines
      • Shingles
      • Smallpox
      • TB
      • Tetanus
      • Typhoid
      • Yellow Fever Vaccine
    • Vaccines and the Media
  • WORLD NEWS
    • Africa
    • Asia
    • Australasia
    • Europe
    • North America
    • South America
  • RESEARCH
    • Cancer Research
    • Cervarix Vaccine
    • Gardasil/Silgard Vaccine
    • Human Pap. Research
    • Immunization Practices
    • Neurology
    • Vaccine Adjuvants
    • Vac. Ingredient Research
    • Vaccine Injuries
    • Vaccine Preservatives
    • Vaccine Related Research
    • Vaccine Safety
  • CITIZENS SPEAK
    • Cervical Cancer Debate
    • HPV Vax
      • Australian Concerns
      • Canadian Concerns
      • Irish Concerns
      • Spain Concerns
      • UK Concerns
      • United States Concerns
You are here: Home / Media / About / SANE Vax Press Releases / HPV Vaccines: What exactly are they effective against?

HPV Vaccines: What exactly are they effective against?

March 20, 2011 By Jonathan 1 Comment

Since HPV vaccines have not been proven to prevent cancer, the CDC lists three alternate ways to judge the vaccines’ efficacy. None of them work. Where does that leave medical consumers?

FOR IMMEDIATE RELEASE

PRLog (Press Release) – Mar 19, 2011 – According to the prescribing information packet, GARDASIL is a vaccine indicated in girls and women 9 through 26 years of age for the prevention of the following diseases caused by Human Papillomavirus (HPV) types included in the vaccine:

•   Cervical, vulvar, and vaginal cancer caused by HPV types 16 and 18
•   Genital warts (condyloma acuminata) caused by HPV types 6 and 11
•   And the following precancerous or dysplastic lesions caused by HPV types 6, 11, 16, and 18:
•   Cervical intraepithelial neoplasia (CIN) grade 2/3 and Cervical adenocarcinoma in situ (AIS)
•   Cervical intraepithelial neoplasia (CIN) grade 1
•   Vulvar intraepithelial neoplasia (VIN) grade 2 and grade 3
•   Vaginal intraepithelial neoplasia (VaIN) grade 2 and grade 3

GARDASIL is indicated in boys and men 9 through 26 years of age for the prevention of genital warts (condyloma acuminata) caused by HPV types 6 and 11.

The prescribing information packet for Gardasil’s competitor states: CERVARIX® is indicated for the prevention of the following diseases caused by oncogenic human papillomavirus (HPV) types 16 and 18 [see Clinical Studies (14)]:

•   Cervical cancer
•   Cervical intraepithelial neoplasia (CIN) grade 2 or worse and adenocarcinoma in situ, and
•   Cervical intraepithelial neoplasia (CIN) grade 1.

CERVARIX is approved for use in females 10 through 25 years of age.

Examine the facts. Neither vaccine has been proven to prevent cancer. The CDC says, “While there are well-established cancer registries in the United States, it will take decades before the impact of vaccine on cervical cancer is observed. More proximal measures of vaccine impact include outcomes such as prevalence of HPV vaccine types, incidence of cervical precancers and genital warts.”

HPV Prevalence:  HPV tests currently available to American medical consumers generate both false positive and false negative reports. (See this report for verification.)

Unless a test is approved for general use that uses HPV short-targeting DNA sequencing (See reliable gentyping), HPV prevalence cannot be accurately monitored to determine vaccine efficacy.

Precancerous lesions:  In the natural history of cervical cancer development only a small fraction of the CIN 2 lesions will progress to CIN 3 lesions; and only a small fraction of CIN 3 lesions will progress to cervical cancer. Theoretically, you cannot have cervical cancer without first having various grades of cervical intraepithelial neoplasia (CIN). However, when most of these lesions reverse on their own, it is hardly an accurate way to determine efficacy of a ‘cancer’ vaccine.Genital Warts:  There are few reports of the rates of genital warts in the United States prior to 2000. The current statistical reports are primarily gathered from STD clinics in larger cities throughout the United States. These are then extrapolated to estimate the rates for the rest of the country. With no accurate baseline to compare to, genital warts are not an adequate judge of vaccine efficacy either.

The only way left to monitor HPV vaccine efficacy is to determine whether the vaccine-related genotypes decline after vaccination. Without a reliable short target DNA sequencing test available to the general medical consumer, this is not possible.

This leaves people having to trust the authorities and wait for decades to see if HPV vaccines actually reduce the incidence of cervical cancer. The SaneVax Team believes this is not a viable option.

The CDC stressed the importance of post-vaccination HPV monitoring. Medical consumers need to know if they have been exposed to a vaccine-relevant HPV before vaccination not only to avoid potential serious side effects, but to avoid wasting their precious health care dollars on a vaccine that will do nothing for them if they have already been exposed.

Consider the following to results of searches of the VAERS database:

•   106 reports of anogenital warts found after HPV vaccination
•   222 reports of papillomavirus infections found after HPV vaccination
•   29 reports of cervical cancer after HPV vaccination

The VAERS database has its limitations, but for now it is the only adverse event reference source available to the public. The reports above may be related to HPV genotypes not included in the vaccines. Then again, they may be caused by the same genotypes included in the vaccines. Without proper DNA sequencing, no one will ever know.

When a vaccine has no proven efficacy against the disease it is intended to prevent, no risk to the consumer is acceptable.

Sources:
1. https://sanevax.org/research-blog/
2.https://sanevax.org/prescribing-information-for-cervarix/
3. http://www.ncbi.nlm.nih.gov/pubmed/12636951?dopt=Abstrac …
4.
https://www.fbo.gov/…

https://www.fbo.gov/…
5.http://www.sciencedirect.com/…

Read More…

Related

Filed Under: SANE Vax Press Releases Tagged With: Alopecia totalis, Autoimmune Diseases, cervarix, Cervical Cancer HPV, estrogen, GlaxoSmithKline, HPV, Merck, pharmaceuticals, Sane Vax, STD's, vaccinations, Vaccine Adverse Reactions

Trackbacks

  1. Cervical adenocarcinoma | Upriverranch says:
    March 26, 2011 at 4:54 pm

    […] HPV Vaccines: What exactly are they effective against? – SaneVax … […]

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Follow Us

SaneVax on FacebookSaneVax on TwitterSaneVax on LinkedInSaneVax on YoutubeSaneVax RSS Feed

Help Support SaneVax

Notice: We need your support. This massive research & presentation comes from a team of volunteers. We need your help to keep this critical information available.



SaneVax relies on support from participants like you. We are a 501 (c)(3) non-profit corporation, donations are tax deductible. Help keep this venue available and support the spirit – Thank you!

This Week’s Survivor

Sarah from Utah

Categories

Links

  • Creating an HPV Industry
  • File a VAERS Report
  • Gardasil and Unexplained Deaths
  • HPV Industry Timeline
  • HPV Mechanisms of Action in Women
  • HPV Vaccine Fact Sheet
  • Petition: Rescind HPV Vaccine Approval
  • Presentation to the FDA
  • Supreme Court Arguments

HPV Vaccine VAERS Reports

Description 12/14/2019  TOTAL
Disabled 3,092
Deaths 523
Did Not Recover 13,072
Abnormal Smear 695
Cervical Cancer 186
Infertility 52
Life-threatening 1,001
Emergency Room 15,419
Hospitalized 6,448
Extended Hosp. Stay 304
Serious 9,497
Total Adverse Events 64,270

Access expanded report here.

Related

Subscribe2


 

Log In

Featured Video

Gardasil: Is it really coincidence? The Vaccine Truth

News

SaneVax News Blog!
News

Videos

Safety • Victims • Pharma
No Genetic Epidemic

Contact

Contact S.A.N.E.Vax
S.A.N.E.VAX log thumbnail

Copyright © 2023 SaneVax, Inc. · Site by TheWebElves.com a div. of KalaRhythms.org · Log in